PTEN is altered in 5–14% of CRC [33,116], resulting in PI3K/AKT signaling upregulation [117] and decreased sensitivity of CRC tumors to anti-EGFR antibodies [33,118,119]. This evidence concerns the gene AKT1 and colorectal carcinoma.